Conference Coverage: ASCO GU 2023 Highlights
Expert perspectives and strategic insights on the latest therapeutic developments in GU cancer treatment from the 2023 ASCO GU Cancers Symposium, and implications on individualized clinical decision-making.
Daniel Petrylak, MD
Yale Cancer Center, New Haven, CT, USA
Download the meeting agendaView Agenda
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
A report will be produced that is based on the meeting, and will discuss the following topics
- Prostate Cancer Part 1 – Hormonal Therapies and Chemotherapies
- Prostate Cancer Part 2 – Targeted Therapies
- Bladder Cancer Part 1 – ADCs
- Bladder Cancer Part 2 – PARP Inhibitors and Immunotherapies
- Renal Cell Carcinoma
Complete the form below to receive additional information.